# A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study

> **NCT05095571** · NA · RECRUITING · sponsor: **Haukeland University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** EH301 (Nicotinamide Riboside/Pterostilbene)

## Key facts

- **NCT ID:** NCT05095571
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-07
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095571, "A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05095571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*